What a Succession Diagnosis Delivers, and Why It Comes First

A succession diagnosis delivers three things before anyone talks price: an honest placement of where your company stands, the bottleneck that slows your handover most, and a concrete agenda for the next 90 days. It comes first because every later step, valuation, buyer search, negotiation, rests on what it reveals. Most owners start at the other end, looking for an advisor or a buyer before they know what they actually have. That is understandable, because a succession feels like a sale, and a sale needs a market. Yet those who enter through the transaction instead of through preparation usually pay the highest price for it.

The most common entry mistake

In practice it often unfolds the same way. The owner speaks with the fiduciary, who recommends an M&A boutique, the boutique produces a valuation, and suddenly you are in the middle of a process without ever having asked: Are we even ready? Each of these steps is sensible on its own. Taken together, they lead right past the real question.

The problem is not the valuation, but its sequence. A figure that rests on a company still entirely dependent on one person, whose processes live in the heads of individual employees and whose books mix private and business items, is not a basis for negotiation but a snapshot of the weaknesses. Those who enter through the transaction instead of through preparation make the most expensive mistake of the entire succession.

What a diagnosis delivers

A structured succession diagnosis analyses the company systematically along the dimensions that become relevant in every succession, regardless of the path chosen (sale, family-internal handover, or internal takeover). It makes no claim to completeness. Its aim is prioritisation. Nor is it a valuation: it does not tell you what the company is worth, but whether the company is ready to be handed over at all, which is exactly the question a valuation quietly assumes has been answered.

It answers three sober questions:

• What is blocking us most strongly today?
• Which dimension, if improved, would have the greatest impact on success?
• What can we concretely tackle in the next 90 days?

This is deliberately less than a full due diligence promises, and precisely for that reason it is worth more. A diagnosis turns a diffuse unease into an ordered list you can actually work on.

The yardstick behind these questions is a score across the ten dimensions of succession readiness, from the owner's decision and the depth of the management team to financial transparency and the transferability of ownership. The full framework, with each dimension phrased as a question you can score yourself, is set out in our guide to the ten dimensions of a succession ready company. For many owners it is the first time they see the company from an informed outside view, and a company rarely fails everywhere at once: usually one or two weak dimensions quietly hold the rest hostage.

What you know after one session

After a single structured session, you know three things you could not clearly name before.

First, where you stand compared with well-prepared companies, not as a school grade but as an honest placement. Second, which three dimensions are slowing your handover most, that is, your real bottleneck. Third, which concrete measures are due for the next 90 days: documenting a process, building a deputy structure, formalising a shareholders' agreement, or simply beginning the conversation with the family that you have so far avoided. And because preparation alone takes months, the session also settles the timing question: starting earlier than feels necessary is what keeps every option open.

A good diagnosis does not deliver a ten-year plan, but an honest answer to two questions: Where do we stand, and what comes first?

That is the difference between a plan and a hope. A ten-year plan sounds reassuring, yet it falls apart at the first unexpected offer. An ordered list of the next steps holds. It turns a succession from something that happens to you into something you lead.

This is exactly where preparation begins, not with the price and not with the search for a buyer, but with the question of whether the company can even carry this yet. Those who answer this question first negotiate later from an entirely different position.

If you would like this outside view: the structured succession diagnosis from TransActum360 measures your company across all ten dimensions of succession readiness and delivers a prioritised plan, in a single session you can book directly.